---
title: "Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b... — FDA record D-0360-2022 | Is It on Recall"
description: "Failed Impurities/Degradation Specifications"
url: https://isitonrecall.com/recall/fda-drug-d-0360-2022-cefixime-400-mg-capsule-packaged-in-a-2-count-bottle-ndc-70518-2749-02-b-2-count-blister-pack-ndc-70/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-0... — FDA record D-0360-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Dec 29, 2021. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-03), Rx only, MFG: Ascend Labs, LLC, Montvale, NJ 07645
- **Reason**: Failed Impurities/Degradation Specifications
- **Classification**: Class II
- **Recalling firm**: RemedyRepack Inc.
- **Quantity**: a) 716 bottles/ 1432 capsules b) 223 blister packs/ 466 capsules
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0360-2022

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0360-2022%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot #: a) B1429436-110821, Exp 07/2022; B1429434-110821, Exp 11/2022; B1429435-110821, Exp 11/2022; B1279449-072021, Exp 07/2022; B1279457-072021, Exp 07/2022; B1279442-072021,Exp 07/2022; B1057718-012621, Exp 01/2022; B1057727-012621, Exp 01/2022; b) B1358139-092121, Exp 03/2022; B1424654-110421, B1437578-111421, Exp 05/2022 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Product was distributed to two direct accounts in MI and PA.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Michigan](https://isitonrecall.com/state/michigan/)
- [Pennsylvania](https://isitonrecall.com/state/pennsylvania/)

## Dates in the source

- **Report date**: Jan 12, 2022
- **Recall initiation date**: Dec 29, 2021
- **Center classification date**: Jan 5, 2022
- **Termination date**: Apr 14, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0360-2022%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [RemedyRepack Inc. records](https://isitonrecall.com/brand/remedyrepack-inc/)